Entries by Carolyn Lowry

200 Reasons to Celebrate!

Fusion Antibodies are celebrating their 200th Antibody Humanization project, cementing our place as a leading CRO in antibody engineering services.

Fusion Antibodies make key Covid-19 Reagents available

As part of our efforts to combat the Covid-19 pandemic, We have designed and expressed a panel of unique recombinant protein antigens to assist in the search for a neutralising therapeutic antibody against SARS-CoV 2. ​